The Directors team at Renovacor is responsible for overseeing various strategic aspects of the company's operations, including preclinical development, regulatory affairs, clinical strategy, and business development. They collaborate to guide the company’s efforts in developing AAV-based gene therapies for cardiovascular and CNS diseases, ensuring alignment with scientific and commercial goals.
View all